Skip to content
CAPITAL STRUCTUREDrug Manufacturers - General

TTK Healthcare moves to reshape its capital structure

TTK HealthcareTTKHLTCARE

TL;DR

The proposed NCRPS terms are: Dividend/coupon: 9.5% per annum. Redemption tenor: 15 months, redeemable at par.

What are the specific terms of the proposed NCRPS, including the dividend/coupon rate, the redemption tenor, and the ratio of the bonus issue relative to existing equity shares?

The proposed NCRPS terms are:

  • Dividend/coupon: 9.5% per annum.
  • Redemption tenor: 15 months, redeemable at par.
  • Bonus ratio: 5:1 — five NCRPS for every one existing equity share held on the record date.
  • Status: The issue remains subject to statutory and regulatory approvals, including NCLT, stock-exchange, shareholder and creditor approvals. [1]

Which specific reserve accounts will be utilized to fund this bonus issue, and how does the capitalization of these reserves impact the company's reported net worth and book value per share?

The proposed bonus issue will be funded from general reserves and/or retained earnings; the filing does not prescribe the exact debit split between the two accounts. As of 30 September 2026, the reported balances were:

  • General reserves: ₹78.48 Cr
  • Retained earnings: ₹1,222.86 Cr
  • Total identified reserves: ₹1,301.34 Cr

The proposed NCRPS capitalization is approximately ₹706.52 Cr, so the identified reserves are sufficient. General reserves alone are not sufficient; even if the entire ₹78.48 Cr were used, at least ₹628.04 Cr would have to come from retained earnings. These are derived amounts from the company’s disclosed balances and proposed issue size. [2]

Impact on net worth and book value per share

The transaction is a reclassification of reserves into NCRPS capital, not a cash-funded issue. The company will issue 7,06,51,665 NCRPS of ₹100 each as a bonus, while the number of ordinary equity shares remains unchanged. [2]

The accounting outcome depends on how the redeemable preference shares are presented in the post-issue financial statements:

  • If the NCRPS are included within equity: reserves would decline by ₹706.52 Cr and preference share capital would increase by the same amount. Total net worth would be unchanged mechanically. Using Q2 FY27 standalone total equity of ₹1,346.5 Cr and the unchanged equity-share count, the reported book value per equity share would remain approximately ₹95.30, before subsequent dividends, profits or redemption effects. [3] [4]
  • If the redeemable NCRPS are presented outside equity as a liability: equity attributable to ordinary shareholders could fall by roughly ₹706.52 Cr. On a purely illustrative Q2 FY27 pro forma basis, equity would be about ₹639.98 Cr and book value per ordinary share about ₹45.29. This is a derived scenario, not a reported post-issue figure; the filing does not specify the final accounting classification.

The key point is that reserve capitalization itself does not create value. It changes the composition of shareholders’ funds, while the NCRPS introduce a 15-month redemption obligation and a 9.5% annual dividend entitlement. Redemption is also proposed to be funded from general reserves and/or retained profits, making the later settlement—not the initial reserve transfer—the main cash-flow event. [2]

The scheme remains subject to the required approvals, and the definitive impact on reported net worth and book value per share will only be clear once the NCRPS are allotted and reflected in the financial statements. [2]

How does the proposed redemption schedule for these NCRPS align with the company's current cash flow generation and existing debt repayment obligations, as disclosed in the latest annual report?

Verdict: On the latest annual figures, the proposed NCRPS redemption is not covered by demonstrated operating cash generation. The structure appears to rely on future cash accumulation, monetisation of assets/investments, or refinancing rather than FY26 operating cash flow. The existing debt balance is modest, but the cited disclosures do not provide a maturity-by-maturity repayment schedule against which to test the timing.

Redemption obligation versus cash generation

The NCRPS are proposed to be redeemed at par 15 months from allotment, or earlier at the Board’s option. The allotment itself is subject to the Scheme and requisite approvals. The principal amount is ₹706.52 Cr, with a 9.5% annual dividend [2].

If held for the full 15 months, the mechanical cash requirement would be:

  • Principal redemption: ₹706.52 Cr [2]
  • 15-month dividend: approximately ₹83.90 Cr, derived from ₹706.52 Cr × 9.5% × 15/12 [2]
  • Total potential cash outflow: approximately ₹790.42 Cr, assuming the full-period dividend accrues and is paid with redemption.

Against this:

  • FY26 operating cash flow was negative ₹21.15 Cr [5].
  • Operating cash flow was also negative in FY24 and FY25, at ₹4.94 Cr and ₹3.98 Cr of outflow, respectively [6] [7].
  • FY26 cash and equivalents were only ₹21.88 Cr [8].

Thus, the NCRPS principal alone is approximately 33.4 times the absolute FY26 operating cash outflow, and the potential full redemption-plus-dividend obligation is approximately 36.8 times that amount, derived from the cited figures. This is a balance-sheet obligation substantially larger than the company’s recent operating cash generation.

Interaction with existing debt

FY26 total debt was ₹23.88 Cr [9], rising marginally to ₹25.96 Cr at Q2 FY27 [10]. At Q2 FY27, cash and equivalents were ₹89.84 Cr [11], implying reported net cash of ₹63.88 Cr [12].

That liquidity improvement is helpful, but it does not make the NCRPS redemption self-funded: the ₹706.52 Cr principal is about 7.9 times Q2 FY27 cash, while the estimated ₹790.42 Cr full obligation is about 8.8 times Q2 FY27 cash, derived from the cited figures. The company’s existing debt is small relative to the NCRPS amount, but the available disclosures do not establish whether any debt maturities fall within the 15-month NCRPS window or quantify scheduled principal repayments.

Key structural point

The NCRPS are being issued as a bonus, funded through general reserves and/or retained earnings, rather than through a cash-raising issue [2]. The reported reserves available for capitalization at 30 September 2026 were ₹78.48 Cr of general reserves and ₹1,222.86 Cr of retained earnings [2]. These are accounting reserves, not cash earmarked for redemption. Consequently, the proposal creates a substantial future cash requirement without generating cash at issuance.

Overall: the schedule is compatible with the company’s current balance sheet only if the strong Q2 FY27 cash position is sustained and materially augmented by future cash generation or other funding sources. It is not supported by the latest full-year operating cash-flow record alone, and the lack of a disclosed debt-maturity profile prevents a precise assessment of competing repayment dates.

Sources

  1. [1]TTK Healthcare Scheme of Arrangement Highlights – Perivis — Blog, 2026-11-20T00:00:00
  2. [2]TTK Healthcare Board Outcome: Proposed Bonus Issue of Non-Convertible Redeemable Preference Shares (NCRPS) — 2026-11-20T12:28:07.023000, p.3
  3. [3]Total Equity
  4. [4]Book Value Per Share
  5. [5]TTM Operating Cash Flow
  6. [6]TTM Operating Cash Flow
  7. [7]TTM Operating Cash Flow
  8. [8]Cash and Equivalents
  9. [9]Total Debt
  10. [10]Total Debt
  11. [11]Cash and Equivalents
  12. [12]Net Debt

Keep digging

What are the specific terms of the proposed NCRPS, including the dividend/coupon rate, the redemption tenor, and the ratio of the bonus issue relative to existing equity shares?

Ask Copilot
Logo

Unlock financial AI for your firm